#HealthInnovation #WeightLoss #ChronicCare #PublicHealth #GLP-1 To view or add a comment, sign in New research published in the The BMJ adds an important perspective to the growing discussion around GLP-1 weight-loss medications and what happens when treatment is stopped
In treating our patients, we do so from a medical perspective, rather than from a judgmental willpower or character flaw perspective
The ingredient studies that do exist were conducted on oral doses, and even those show modest results at best
Can I store reconstituted Melanotan-2 at room temperature if I use it within a week
Howard JF Jr, Bril V, Burns TM, Mantegazza R, Bilinska M, Szczudlik A, et al
For patients with severe obesity (BMI 40 or 35 with obesity-related complications), referral for evaluation of bariatric surgery may be appropriate according to American Society for Metabolic and Bariatric Surgery guidelines